Cargando…
Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) treatment regimes are amongst the longest, most intensive and complex used in hematooncology. Despite this, while treatment of pediatric ALL is a success story, we are far from being able to ensure a durable response in adult ALL. This is not due to failure of indu...
Autores principales: | Lee, Lydia, Fielding, Adele K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273927/ https://www.ncbi.nlm.nih.gov/pubmed/22346368 http://dx.doi.org/10.4137/CMO.S7262 |
Ejemplares similares
-
Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011) -
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab, Tareq, et al.
Publicado: (2021) -
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
por: Aumann, Shlomzion, et al.
Publicado: (2022) -
Approach to the Adult Acute Lymphoblastic Leukemia Patient
por: Sas, Valentina, et al.
Publicado: (2019) -
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
por: Wei, Guoqing, et al.
Publicado: (2017)